GSK and Alfasigma announce agreement on worldwide rights for linerixibat March 9, 2026
GSK plc (LSE/NYSE: GSK) and Alfasigma S.p.A. today announced a licence agreement under which Alfasigma will acquire worldwide…
Browsing Tag